Skip to content
value.today

Tulavi Therapeutics, Inc.

Total raised
$15 M
4 rounds on record
Latest round
$1 M
Dec 2021
First round on record
Apr 2018
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Tulavi Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2021$1 MNo. 4Under $2 million

Tulavi Therapeutics, Inc.: Raise no. 4, Dec 2021

Investors in this round

9 investors had bought by the notice of Dec 17, 2021: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Corinne Bright · Executive Officer, Director
  • Amar Sawhney · Director
  • Farhad Khosravi · Director
  • Greg Casciaro · Director
  • Henry Chen · Director
  • Steve Willamson · Director
  • Tara Butler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Geoffrey Leonard, Secretary. Newest notice filed Dec 17, 2021. Read the notice at the SEC.

equitySEC
Feb 2021$8 MNo. 3$2 to $10 million

Tulavi Therapeutics, Inc.: Raise no. 3, Feb 2021

Investors in this round

3 investors had bought by the notice of Mar 2, 2021: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $10 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Corinne Bright · Executive Officer, Director
  • Amar Sawhney · Director
  • Farhad Khosravi · Director
  • Henry Chen · Director
  • Steve Willamson · Director
  • Tara Butler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Geoffrey Leonard, Secretary. Newest notice filed Mar 2, 2021. Read the notice at the SEC.

equitySEC
May 2020$3 MNo. 2$2 to $10 million

Tulavi Therapeutics, Inc.: Raise no. 2, May 2020

Investors in this round

2 investors had bought by the notice of May 12, 2020: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $5 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Corinne Bright · Executive Officer, Director
  • Amar Sawney · Director
  • Farhad Khosravi · Director
  • Henry Chen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Geoffrey Leonard, Secretary. Newest notice filed May 12, 2020. Read the notice at the SEC.

equitySEC
Apr 2018$3 MNo. 1$2 to $10 million

Tulavi Therapeutics, Inc.: Raise no. 1, Apr 2018

Investors in this round

3 investors had bought by the notice of Dec 3, 2018: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $4 M offered; $1 M still to sell
Smallest investment taken
$159,999
What was sold
equity
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Corinne Bright · Executive Officer, Director
  • Farhad Khosravi · Executive Officer, Director
  • Henry Chen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Geoffrey Leonard, Secretary. Newest notice filed Dec 3, 2018 (1 amendment). Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Tulavi Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2021).

    SEC Form D · Dec 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Dec 2021

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Tulavi Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Tulavi Therapeutics, Inc.
NameRoleNamed in
Corinne BrightExecutive officerDec 2021
Farhad KhosraviExecutive officerDec 2018
Amar SawhneyDirectorDec 2021
Corinne BrightDirectorDec 2021
Farhad KhosraviDirectorDec 2021
Greg CasciaroDirectorDec 2021
Henry ChenDirectorDec 2021
Steve WillamsonDirectorDec 2021
Tara ButlerDirectorDec 2021
Amar SawneyDirectorMay 2020